Lv61
1900 积分 2022-06-02 加入
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis
1个月前
已完结
Homology modeling in drug discovery: current trends and applications
2个月前
已完结
Regulation of metastatic organotropism
3个月前
已完结
Metastasis-Initiating Cells and Ecosystems
3个月前
已完结
Metastasis
3个月前
已完结
Lip and Oral Cavity Squamous Cell Carcinoma
4个月前
已完结
POS0047 SALIVARY GLAND IMMUNE-ORGANOIDS AS A MODEL TO INVESTIGATE SJOGREN'S DISEASE
4个月前
已关闭
Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer
4个月前
已完结
Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy
5个月前
已完结
Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy
5个月前
已完结
皖公网安备34019202002308
